Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Emery

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Health Management Technology|May 8, 2012
How Stage 2 affects record release. Changes will drive organizations to implement a patient portal or personal health record applicationSteve Emery
Journal of AHIMA|March 19, 2011
Electronic copy versus electronic accessSteve Emery, Jan McDavid
Journal of AHIMA|April 8, 2010
Compliance in practice: mitigating risk in clinics and physician practicesSteve Emery, Jan McDavid, Deborah Robb
BMJ (Clinical Research Ed.)|May 6, 2008
Reproductive liberty and deafness: Clause 14(4)(9) of embryo bill should be amended or deletedSteve Emery, Teresa Blankmeyer Burke, Anna Middleton, et al.
Cancer Gene Therapy|October 19, 2002
Adenovirus vector-mediated delivery of the prodrug-converting enzyme carboxypeptidase G2 in a secreted or GPI-anchored form: High-level expression of this active conditional cytotoxic enzyme at the plasma membraneRachel L Cowen, Judith C Williams, Steve Emery, et al.
Nature Medicine|August 20, 2003
A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccinesVy Phan, Fiona Errington, S Chiat Cheong, et al.
Molecular Cancer Therapeutics|January 8, 2010
A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical modelsJeffrey L Brown, Z Alexander Cao, Maria Pinzon-Ortiz, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Health Management Technology|May 8, 2012
How Stage 2 affects record release. Changes will drive organizations to implement a patient portal or personal health record applicationSteve Emery
Journal of AHIMA|March 19, 2011
Electronic copy versus electronic accessSteve Emery, Jan McDavid
Journal of AHIMA|April 8, 2010
Compliance in practice: mitigating risk in clinics and physician practicesSteve Emery, Jan McDavid, Deborah Robb
BMJ (Clinical Research Ed.)|May 6, 2008
Reproductive liberty and deafness: Clause 14(4)(9) of embryo bill should be amended or deletedSteve Emery, Teresa Blankmeyer Burke, Anna Middleton, et al.
Cancer Gene Therapy|October 19, 2002
Adenovirus vector-mediated delivery of the prodrug-converting enzyme carboxypeptidase G2 in a secreted or GPI-anchored form: High-level expression of this active conditional cytotoxic enzyme at the plasma membraneRachel L Cowen, Judith C Williams, Steve Emery, et al.
Nature Medicine|August 20, 2003
A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccinesVy Phan, Fiona Errington, S Chiat Cheong, et al.
Molecular Cancer Therapeutics|January 8, 2010
A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical modelsJeffrey L Brown, Z Alexander Cao, Maria Pinzon-Ortiz, et al.
Pageof 1